Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Payables (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Payables for 2 consecutive years, with $3.8 million as the latest value for Q3 2023.

  • On a quarterly basis, Payables fell 5.51% to $3.8 million in Q3 2023 year-over-year; TTM through Sep 2023 was $3.8 million, a 5.51% decrease, with the full-year FY2022 number at $2.6 million, changed N/A from a year prior.
  • Payables was $3.8 million for Q3 2023 at LENZ Therapeutics, up from $2.7 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $4.0 million in Q3 2022 to a low of $2.0 million in Q1 2023.